{"entity":{"type":"insider","cik":"0001346981","url":"/insider/0001346981","json_url":"/insider/0001346981.json","name":"Cohen Kenneth M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":28,"n_filings":19,"first":"2006-09-27","last":"2018-01-24","span_basis":"filed_date"},"name_variants":[{"name":"Cohen Kenneth M","source":"filing","n_filings":19,"first_seen":"2006-09-27","last_seen":"2018-01-24"}],"transactions":[{"id":6769717,"accession":"0001415889-18-000114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-18-000114","line_url":"/filing/0001415889-18-000114#line-2","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17996.0,"shares_display":"17,996","price_per_share":0.84,"price_display":"0.84","price_state":"stated","total_value":15116.64,"total_display":"15,116.64","total_whole":"15,117","shares_owned_after":78355.0,"shares_owned_after_display":"78,355","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-24","filed_date":"2018-01-24","scope":"insider"},{"id":6769714,"accession":"0001415889-18-000114","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-18-000114","line_url":"/filing/0001415889-18-000114#line-1","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":17444.0,"shares_display":"17,444","price_per_share":0.87,"price_display":"0.87","price_state":"stated","total_value":15176.28,"total_display":"15,176.28","total_whole":"15,176","shares_owned_after":96351.0,"shares_owned_after_display":"96,351","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-23","filed_date":"2018-01-24","scope":"insider"},{"id":2263730,"accession":"0001415889-16-006923","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-16-006923","line_url":"/filing/0001415889-16-006923#line-1","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3119.0,"shares_display":"3,119","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":6014.0,"shares_owned_after_display":"6,014","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-17","filed_date":"2016-08-19","scope":"insider"},{"id":8154597,"accession":"0001415889-15-001879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-15-001879","line_url":"/filing/0001415889-15-001879#line-1","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":2.3,"price_display":"2.30","price_state":"stated","total_value":8050.0,"total_display":"8,050.00","total_whole":"8,050","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-22","filed_date":"2015-05-26","scope":"insider"},{"id":6878747,"accession":"0001209191-14-076489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-076489","line_url":"/filing/0001209191-14-076489#line-1","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":4500.0,"total_display":"4,500.00","total_whole":"4,500","shares_owned_after":17616.0,"shares_owned_after_display":"17,616","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-17","filed_date":"2014-12-18","scope":"insider"},{"id":7020580,"accession":"0001209191-14-076228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-076228","line_url":"/filing/0001209191-14-076228#line-1","is_derivative":false,"issuer_cik":"0001109196","issuer_name":"MABVAX THERAPEUTICS HOLDINGS, INC.","issuer_ticker":"MBVX","issuer_name_source":null,"issuer_url":"/issuer/0001109196","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":2.41,"price_display":"2.41","price_state":"stated","total_value":9640.0,"total_display":"9,640.00","total_whole":"9,640","shares_owned_after":15116.0,"shares_owned_after_display":"15,116","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2014-12-17","scope":"insider"},{"id":6852853,"accession":"0001209191-07-026055","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-026055","line_url":"/filing/0001209191-07-026055#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23795.0,"shares_display":"23,795","price_per_share":15.1368,"price_display":"15.14","price_state":"stated","total_value":360180.156,"total_display":"360,180.16","total_whole":"360,180","shares_owned_after":45833.0,"shares_owned_after_display":"45,833","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-25","filed_date":"2007-04-27","scope":"insider"},{"id":7798423,"accession":"0001209191-07-023068","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-07-023068","line_url":"/filing/0001209191-07-023068#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4800.0,"shares_display":"4,800","price_per_share":12.5462,"price_display":"12.55","price_state":"stated","total_value":60221.76,"total_display":"60,221.76","total_whole":"60,222","shares_owned_after":69628.0,"shares_owned_after_display":"69,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-09","filed_date":"2007-04-09","scope":"insider"},{"id":7798420,"accession":"0001209191-07-023068","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-023068","line_url":"/filing/0001209191-07-023068#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200.0,"shares_display":"200","price_per_share":12.5,"price_display":"12.50","price_state":"stated","total_value":2500.0,"total_display":"2,500.00","total_whole":"2,500","shares_owned_after":74428.0,"shares_owned_after_display":"74,428","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-04-05","filed_date":"2007-04-09","scope":"insider"},{"id":7695371,"accession":"0001209191-07-018089","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-018089","line_url":"/filing/0001209191-07-018089#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.5258,"price_display":"12.53","price_state":"stated","total_value":62629.0,"total_display":"62,629.00","total_whole":"62,629","shares_owned_after":74628.0,"shares_owned_after_display":"74,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-03-14","filed_date":"2007-03-16","scope":"insider"},{"id":7903181,"accession":"0001209191-07-011963","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-011963","line_url":"/filing/0001209191-07-011963#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":12.9581,"price_display":"12.96","price_state":"stated","total_value":64790.5,"total_display":"64,790.50","total_whole":"64,791","shares_owned_after":79628.0,"shares_owned_after_display":"79,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-02-15","filed_date":"2007-02-20","scope":"insider"},{"id":8071672,"accession":"0001209191-07-002570","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-07-002570","line_url":"/filing/0001209191-07-002570#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.4737,"price_display":"13.47","price_state":"stated","total_value":67368.5,"total_display":"67,368.50","total_whole":"67,369","shares_owned_after":84628.0,"shares_owned_after_display":"84,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-01-03","filed_date":"2007-01-05","scope":"insider"},{"id":3486967,"accession":"0001209191-06-066306","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-06-066306","line_url":"/filing/0001209191-06-066306#line-3","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3315.0,"shares_display":"3,315","price_per_share":15.0043,"price_display":"15.00","price_state":"stated","total_value":49739.2545,"total_display":"49,739.25","total_whole":"49,739","shares_owned_after":89628.0,"shares_owned_after_display":"89,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-12-20","filed_date":"2006-12-20","scope":"insider"},{"id":3486964,"accession":"0001209191-06-066306","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-066306","line_url":"/filing/0001209191-06-066306#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4713.0,"shares_display":"4,713","price_per_share":15.001,"price_display":"15.00","price_state":"stated","total_value":70699.713,"total_display":"70,699.71","total_whole":"70,700","shares_owned_after":92943.0,"shares_owned_after_display":"92,943","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-12-19","filed_date":"2006-12-20","scope":"insider"},{"id":3486962,"accession":"0001209191-06-066306","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-066306","line_url":"/filing/0001209191-06-066306#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1502.0,"shares_display":"1,502","price_per_share":15.0317,"price_display":"15.03","price_state":"stated","total_value":22577.6134,"total_display":"22,577.61","total_whole":"22,578","shares_owned_after":97656.0,"shares_owned_after_display":"97,656","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-12-18","filed_date":"2006-12-20","scope":"insider"},{"id":4105828,"accession":"0001209191-06-063152","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-063152","line_url":"/filing/0001209191-06-063152#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.1049,"price_display":"13.10","price_state":"stated","total_value":65524.5,"total_display":"65,524.50","total_whole":"65,525","shares_owned_after":99158.0,"shares_owned_after_display":"99,158","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-12-01","filed_date":"2006-12-05","scope":"insider"},{"id":3938021,"accession":"0001209191-06-059692","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-06-059692","line_url":"/filing/0001209191-06-059692#line-3","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":64.0,"shares_display":"64","price_per_share":15.02,"price_display":"15.02","price_state":"stated","total_value":961.28,"total_display":"961.28","total_whole":"961","shares_owned_after":104158.0,"shares_owned_after_display":"104,158","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-11-15","filed_date":"2006-11-15","scope":"insider"},{"id":3938019,"accession":"0001209191-06-059692","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-059692","line_url":"/filing/0001209191-06-059692#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1045.0,"shares_display":"1,045","price_per_share":15.0338,"price_display":"15.03","price_state":"stated","total_value":15710.321,"total_display":"15,710.32","total_whole":"15,710","shares_owned_after":104222.0,"shares_owned_after_display":"104,222","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-11-14","filed_date":"2006-11-15","scope":"insider"},{"id":3938017,"accession":"0001209191-06-059692","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-059692","line_url":"/filing/0001209191-06-059692#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":398.0,"shares_display":"398","price_per_share":15.1106,"price_display":"15.11","price_state":"stated","total_value":6014.0188,"total_display":"6,014.02","total_whole":"6,014","shares_owned_after":105267.0,"shares_owned_after_display":"105,267","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-11-13","filed_date":"2006-11-15","scope":"insider"},{"id":5260643,"accession":"0001209191-06-058719","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-058719","line_url":"/filing/0001209191-06-058719#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50.0,"shares_display":"50","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":750.0,"total_display":"750.00","total_whole":"750","shares_owned_after":105665.0,"shares_owned_after_display":"105,665","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-11-07","filed_date":"2006-11-09","scope":"insider"},{"id":3659495,"accession":"0001209191-06-057737","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-057737","line_url":"/filing/0001209191-06-057737#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":14.4538,"price_display":"14.45","price_state":"stated","total_value":72269.0,"total_display":"72,269.00","total_whole":"72,269","shares_owned_after":105715.0,"shares_owned_after_display":"105,715","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-11-01","filed_date":"2006-11-03","scope":"insider"},{"id":5428592,"accession":"0001209191-06-055996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-055996","line_url":"/filing/0001209191-06-055996#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":118.0,"shares_display":"118","price_per_share":15.025,"price_display":"15.02","price_state":"stated","total_value":1772.95,"total_display":"1,772.95","total_whole":"1,773","shares_owned_after":110715.0,"shares_owned_after_display":"110,715","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-10-23","filed_date":"2006-10-25","scope":"insider"},{"id":3777009,"accession":"0001209191-06-054353","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-054353","line_url":"/filing/0001209191-06-054353#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3172.0,"shares_display":"3,172","price_per_share":13.151,"price_display":"13.15","price_state":"stated","total_value":41714.972,"total_display":"41,714.97","total_whole":"41,715","shares_owned_after":110833.0,"shares_owned_after_display":"110,833","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-10-06","filed_date":"2006-10-10","scope":"insider"},{"id":3777007,"accession":"0001209191-06-054353","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-054353","line_url":"/filing/0001209191-06-054353#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1219.0,"shares_display":"1,219","price_per_share":12.5686,"price_display":"12.57","price_state":"stated","total_value":15321.1234,"total_display":"15,321.12","total_whole":"15,321","shares_owned_after":114005.0,"shares_owned_after_display":"114,005","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-10-05","filed_date":"2006-10-10","scope":"insider"},{"id":4192713,"accession":"0001209191-06-053580","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-053580","line_url":"/filing/0001209191-06-053580#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":84.0,"shares_display":"84","price_per_share":12.5008,"price_display":"12.50","price_state":"stated","total_value":1050.0672,"total_display":"1,050.07","total_whole":"1,050","shares_owned_after":115224.0,"shares_owned_after_display":"115,224","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-10-04","filed_date":"2006-10-04","scope":"insider"},{"id":4192707,"accession":"0001209191-06-053580","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-053580","line_url":"/filing/0001209191-06-053580#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":525.0,"shares_display":"525","price_per_share":12.6217,"price_display":"12.62","price_state":"stated","total_value":6626.3925,"total_display":"6,626.39","total_whole":"6,626","shares_owned_after":115308.0,"shares_owned_after_display":"115,308","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-10-02","filed_date":"2006-10-04","scope":"insider"},{"id":5259343,"accession":"0001209191-06-051726","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-06-051726","line_url":"/filing/0001209191-06-051726#line-2","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1311.0,"shares_display":"1,311","price_per_share":12.6227,"price_display":"12.62","price_state":"stated","total_value":16548.3597,"total_display":"16,548.36","total_whole":"16,548","shares_owned_after":115833.0,"shares_owned_after_display":"115,833","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-09-26","filed_date":"2006-09-27","scope":"insider"},{"id":5259340,"accession":"0001209191-06-051726","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-06-051726","line_url":"/filing/0001209191-06-051726#line-1","is_derivative":false,"issuer_cik":"0001339455","issuer_name":"Somaxon Pharmaceuticals, Inc.","issuer_ticker":"SOMX","issuer_name_source":null,"issuer_url":"/issuer/0001339455","owner_cik":"0001346981","owner_name":"Cohen Kenneth M","owner_display_name":"Cohen Kenneth M","owner_url":"/insider/0001346981","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3689.0,"shares_display":"3,689","price_per_share":12.8372,"price_display":"12.84","price_state":"stated","total_value":47356.4308,"total_display":"47,356.43","total_whole":"47,356","shares_owned_after":117114.0,"shares_owned_after_display":"117,114","ownership_form":"I","is_10b5_1":null,"transaction_date":"2006-09-25","filed_date":"2006-09-27","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":28,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":4,"open_market":true},{"code":"S","label":"Open-market sale","n":24,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":28},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001109196","name":"MABVAX THERAPEUTICS HOLDINGS, INC.","url":"/issuer/0001109196","role":"Director","n_filings":5,"first_seen":"2014-12-17","last_seen":"2018-01-24"},{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Director, Officer (President and CEO)","n_filings":14,"first_seen":"2006-09-27","last_seen":"2007-04-27"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001346981","retrieved_at":"2026-08-26T20:22:29+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}